MedTrace Logo

Investigation to Assess the Effects of Drug-COATED Balloons for Treatment of Plaques Erosions Causing Acute Coronary Syndromes

NCT07783880 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2026-08-25

No results posted yet for this study

Summary

Drug eluting balloon angioplasty might be a better alternative than medical treatment or stenting in subjects with plaque erosion, which is the second most common cause of myocardial infarction.

The main objective of this pilot study is to gain clear insights on the effect of percutaneous coronary intervention (PCI) with size matched DCB (SeQuent) as compared to treatment with GP IIbIIIa inhibitor or heparin \& dual antiplatelet therapy in a predominantly Caucasian population at 2 days and at 1 year after the procedure.

Conditions

  • Myocardial Infarction
  • Percutaneous Coronary Intervention (PCI)
  • Medical Treatment
  • Coronary Computed Tomographic Angiography
  • Computed Tomography
  • Optical Coherence Tomography (OCT)

Interventions

DEVICE

PCI with size matched DCB

Subjects will be treated with PCI with size matched DCB (SeQuent)

DRUG

GP IIbIIIa inhibitor or heparin & dual antiplatelet therapy

GP IIbIIIa inhibitor or heparin \& dual antiplatelet therapy

Sponsors & Collaborators

  • 3W-Research Collaboration Group

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-10-01
Primary Completion
2029-10-01
Completion
2030-01-01

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07783880 on ClinicalTrials.gov